Current status of molecular targeted drugs for EML4-ALK-positive non-small cell lung cancer
DU Ping
LIU Li-hong
Keywords：EML4-ALKnon-small-cell lung cancer (NSCLC)tyrosine kinase inhibitor
Publication Date：2015-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)